Charles Schwab’s Vigil Neuroscience VIGL Stock Holding History

Charles Schwab’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,643	Closed	-$164K	–	3548
2025 Q2	$164K	Buy	+20,643	New	+$92.5K	﹤0.01%	3394
2024 Q2	–	Sell	-41,968	Closed	-$143K	–	3686
2024 Q1	$143K	Hold	41,968	–	–	﹤0.01%	3273
2023 Q4	$142K	Hold	41,968	–	–	﹤0.01%	3316
2023 Q3	$226K	Hold	41,968	–	–	﹤0.01%	3265
2023 Q2	$394K	Buy	+41,968	New	+$397K	﹤0.01%	3156
2022 Q2	–	Sell	-19,198	Closed	-$135K	–	3647
2022 Q1	$135K	Buy	+19,198	New	+$253K	﹤0.01%	3370

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Charles Schwab's VIGL Position: Q3 2025 in Review

Charles Schwab sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 20,643 shares — an estimated $164K sold.

Charles Schwab first reported a position in VIGL in Q1 2022 and held it in 6 quarters. The position peaked at $394K in Q2 2023. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Charles Schwab reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Charles Schwab sold 20,643 Vigil Neuroscience shares in Q3 2025, an estimated $164K.
Charles Schwab first reported a position in Vigil Neuroscience in Q1 2022 and held it in 6 quarters.
Charles Schwab's Vigil Neuroscience position peaked at $394K in Q2 2023.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.